The Clymer Group owns proprietary databases, templates and business processes, and monetizes them, online and in-person, to customers focused on commercializing medical technology. It leverages these proprietary products to attain sustainable competitive advantage for its clients and investors. These strategies are executed by three operating divisions optimized to exploit these growing markets.

MedTechIQ is The Clymer Group® business intelligence digital backbone where we create, discover, manage and share information on advanced medical technologies. The Group's BioIntelligence Database is network hosted on a dynamically reconfigurable visual interface with over 40,000 (growing daily) data entries of wealth relevant information. Categories identified include: pioneering academic research; global subject matter experts; interlinked government funding programs & contract vehicles; relevant industry clustered by market sector & size; regional economic development incubators; and venture capital, philanthropist/angel investors. In devising strategic investment programs, we focus on sector based "Driving Forces". Our interface takes advantage of the structure and nuances embedded in nuggets of medical technology data to "connect the dots" and illuminate wealth relevant relationships between seemingly unrelated data points - thus transforming this data glut into ACTIONABLE INSIGHT!

T2IQ (Technology Transfer Intelligence Quotient) markets our developing "T2IQ Tool Set"  that we use to help our clients meet their technology development objectives with branded strategic consulting, technical services and publications.  T2IQ also markets newsletters, proprietary equity research, expert panel reviews, clinical technology assessments, prospect lists, event planning and a speakers bureau.

PreSeed Ventures embodies our pre-seed stage business development efforts. It leverages insights generated from MedTechIQ, and uses proprietary T2IQ products, to identify and develop technologies emerging primarily from universities and government laboratories.  It specializes in working with "mission oriented" limited partners - strategic corporate investors, regional economic development agencies, business incubators, venture philanthropists, angel investors and venture funds - to commercialize medical innovations. It also partners with industry and government agencies to in-source new medical technologies into their organizations.

Click here to return to the MedTechIQ Social Network!